Corneal Implants Market Size, Industry Analysis Report, Regional Outlook (U.S., Germany, UK, Italy, Russia, China, India, Japan, South Korea, Brazil, Mexico, Saudi Arabia, UAE, South Africa), Application Growth Potential, Competitive Market Growth & Forecast, 2016 – 2024

Corneal Implants Market size is estimated to witness considerable growth prospects from 2016 to 2024.
 

Rising geriatric population base coupled with increasing incidence of eye diseases worldwide should fuel the corneal implants market size over the forecast period. An increase in the number of keratoplasty cases and corneal surgeries should boost industry growth.
 

According to Eye Bank Association of America (EBAA), the number of endothelial keratoplasty cases in the U.S. was over 23,000 in 2012 and corneal surgery was the most adopted choice to avoid blindness and restore the damaged eye.
 

Intracorneal ring segments (ICRS) are made of polymethyl methacrylate (PMMA) and implanted in the deep corneal stroma to adapt to the corneal curvature. Two types of ICRS include Intacs and Ferrara rings. Corneal implants have been developed as a treatment option for corneal ectasia.
 

Keratoprosthesis is a class II medical device proposed to offer transparent optical pathway in a patient with opacified cornea. The U.S. FDA approved Boston KPro and AlphaCor as the permanent implantable keratoprostheses for patients with failed corneal grafts.
 

KAMRA inlay is the first implant device approved by the FDA to improve near vision in patients, who have not undergone the cataract surgery. The inlay is based on the small-aperture optics technology, which offers human eye with a good depth of focus and image quality, accelerating the demand for small aperture corneal implants.  
 

The Implantable Contact Lens (ICL) is used for refractive error correction and used in cases of high-quality vision correction requirements. The phakic intraocular lens has several benefits such as correction of the wide range of nearsightedness, farsightedness, and astigmatism.
 

Ophthalmic clinics contribute majorly to the revenue share owing to a large number of inpatient corneal implant procedures performed in clinics and growing demand for corneal implantable devices.
 

Corneal ectasia application segment is likely to generate significant revenue share. The corneal ectasia is suitable for the treatment only if patient have clear central cornea, and  corneal thickness of over 400 μm at the  place where Intracorneal ring segments (ICRS) are located. The most common postoperative complication is the ring segment extrusion or relocation due to thin placement. The common outcome after ICRS implantation is the existence of intrastromal deposits that gather in the lamellar channel after the implant procedure. The channel deposits consist of intracellular lipids. They do not grow and do not decrease visual performance and accelerates demand for corneal implants over the forecast period.
 

Myopia is the lucrative application for corneal implants. Corneal inlays are used to correct myopia or hyperopia that creates lamellar flap and place synthetic material in the stroma. This modify the optical power of the cornea and change the shape of the anterior corneal surface.The refractive errors can also be corrected by implantation of lens with a high index of refraction than the corneal stroma. Various types of synthetic inlays has been tested, which includes  polysulfone, PMMA and hydrogel.
 

U.S. corneal implants market should drive the regional industry owing to a high prevalence of ophthalmic and ocular conditions and early diagnosis of eye disorders. The availability of advanced products, such as Raindrop Near Vision Inlay, used to correct near vision in patients with presbyopia should stimulate the business growth.
 

Europe corneal implants market size will contribute to the majority of revenue share in the coming years. According to National Statistics, over 200 million people suffer from presbyopia and nearly half of the population in Europe will have presbyopia by 2030. Keratoprosthesis is developed with the EU funded CORNEA project and will be made available under the tradename ‘MIRO CORNEA UR’.
 

Spain corneal implants market will experience lucrative growth over the forecast period. The growth is attributed due to  consumers are willing to spend for eye care in the country. People  take eye health checkup regularly, and they will also look for eye care products for their daily hygiene routines. 
 

Companies operating in the corneal implants market are Neoptics, ReVision Optics, AcuFocus, Presbia, KeraMed, Powervision, Cornea Research Foundation of America, Ocular Systems, Cornea Biosciences, DIOPTEX and SMR OPHTHALMIC. New product launch is the major strategy adopted by the companies in corneal implants market space.
 

What Information does this report contain?